Skip to Content

Lattice Biologics Ltd LBLTF Stock Quote

| Rating as of


Last close prices updated as of Sep 15, 2022, 10:38 AM EST | USD
  • Last Close 0.0001
  • Sector Healthcare
  • Industry Medical Devices
  • Investment Style Small Value
  • Day Range < 0.01  –  < 0.01
  • Year Range < 0.01  –  0.57
  • Market Cap 12,821.8300
  • Volume / Avg 1,530.0 /  1,530.0
  • Price / Sales < 0.01
  • Price / Book 0.13
  • Forward Div Yield
  • Trailing Div Yield

Morningstar‘s Stock Analysis LBLTF

Currency in
Is it the right time to buy or sell?
Is it the right time to buy or sell?

1-Star Price


5-Star Price


Economic Moat


About Quantitative Ratings

Morningstar Quantitative ratings for equities (denoted on this page by) are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies withratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating. Click here for more on how to use these ratings.

Unlock Our Full Analysis With Morningstar Investor

Key Statistics LBLTF

Company Profile LBLTF

Business Description

Lattice Biologics Ltd is a biologic product manufacturing company. It manufactures and markets biologic products to domestic and international markets. The products of the company include ADM dermis, DBM Putty, Bone scaffold, and Others, of which key revenue is derived from Bone scaffold. The biologic products are used in various applications such as enhancing fusion in spine surgery, enhancing breast reconstruction post mastectomy for breast cancer patients, sports medicine applications, promotion of bone in foot and ankle surgery, promotion of skull healing following neurosurgery, and subchondral bone defect repair in knee and other joint surgeries. The company generates its revenue from operations principally carried in the United States of America.

512 East Madison Avenue, Suite A1
Belgrade, MT, 59714
Industry Medical Devices

FAQs for Lattice Biologics Ltd Stock

No. LBLTF does not currently have a forward dividend yield.
Dividend yield allows investors, particularly those interested in dividend-paying stocks, to compare the relationship between a stock’s price and how it rewards stockholders through dividends. The formula for calculating dividend yield is to divide the annual dividend paid per share by the stock price.

Learn more about dividend yield.

LBLTF’s market cap is 12,821.83.
Market capitalization is calculated by taking a company’s share price and multiplying it by the total number of shares. It’s often used to measure a company’s size. In the Morningstar Style Box, large-cap names account for the largest 70% of U.S. stocks, mid-cap names account for the largest 70–90%, and small-cap names are the remaining 10% of companies.

Learn more about market capitalization.

LBLTF’s beta can be found in Trading Information at the top of this page.
A stock’s beta measures how closely tied its price movements have been to the performance of the overall market.

Compare LBLTF’s historical performance against its industry peers and the overall market.